about
Respiratory intermediate (high dependency) unit care in Europe: models of service provision.The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE Study.Management of bronchial secretions with Free Aspire in children with cerebral palsy: impact on clinical outcomes and healthcare resources.Heart and lungs in COPD. Close friends in real life--separate in daily medical practice?Open circuit mouthpiece ventilation: Concise clinical review.Swallowing disorders in tracheostomised patients: a multidisciplinary/multiprofessional approach in decannulation protocols.Sarcoidosis: our experience in the follow-up of 160 patients.Quality of Life Evaluation and Survival Study: a 3-yr prospective multinational study on patients with chronic respiratory failure.Pulmonary rehabilitation at home guided by telemonitoring and access to healthcare facilities for respiratory complications in patients with neuromuscular disease.A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation.Effectiveness and safety of mouthpiece ventilation and nocturnal non-invasive ventilation in patients with kyphoscoliosis: Short and long-term outcomes after an episode of acute respiratory failure.Survival in amyotrophic lateral sclerosis patients on non-invasive ventilation. What can we do more?Predictors of change in exercise capacity after comprehensive COPD inpatient rehabilitation.Percutaneous endoscopic gastrostomy in high risk ALS: insights to effort to drawing a risk mapBAL modifications after antiblastic and immunomodulant therapy in lung cancerActivity of aztreonam in pneumology, Part 2: Influence on phagocytosis and intracellular killing of human alveolar macrophagesThe audit-intervention-reaudit cycle can improve diagnostic standards for chronic obstructive pulmonary disease (COPD)Radiotherapy treatment of the salivary glands, sialorrhea, and non-invasive mechanical ventilation in amyotrophic lateral sclerosis: what are we doing?Airway Clearance with Expiratory Flow Accelerator Technology: Effectiveness of the "Free Aspire" Device in Patients with Severe COPD
P50
Q34414595-1CF281FF-FE0E-498C-876D-9180E208010DQ34552729-36A27128-DE0B-457E-BC7A-8C2C6AACF753Q36481035-462A1EF2-7500-42AB-BAAE-2429C783E7F5Q37174668-10C67DC9-9DB2-4EFC-A814-309F3015D904Q38212845-6E417AF6-4AB9-4445-9797-C93996CF6927Q38227563-1A4473DE-95C8-4C18-B718-5E5DB13F87CDQ43664161-8BA4BB49-FCFD-4ECA-8FB3-49646F1D6D3EQ43906802-8DD3A54A-B977-4F22-8A45-68BE6244D412Q44309561-DB37730B-8D55-4AC6-9205-813F62444126Q47856245-DED6F6E5-EE6E-4287-9AB1-08AC01B9FBE1Q47861302-69EE75FE-D6A8-44E2-87F5-A062449E1916Q51455412-3DD34280-C9AF-4750-B5D4-6687F99D55CEQ51696800-FB423D21-3881-4A56-8C10-0C2FC49B4F65Q57135356-107E299A-B490-40F6-AC7A-45793797B709Q68115505-9344B302-03F5-49CC-8ADD-F0209CD6C725Q72153173-8A09F94A-2560-4265-97B2-21B1C9F5C1B9Q86701315-4153C2C6-527C-4EEB-BC4B-15044374BE9BQ87004759-73ED89B5-8FBA-4762-AD9E-5A336BECD6C5Q92475889-2DBB6ED0-9092-445F-A0D8-FEA9F8B35F42
P50
description
researcher ORCID ID = 0000-0002-3904-820X
@en
wetenschapper
@nl
name
G Garuti
@ast
G Garuti
@en
G Garuti
@es
G Garuti
@nl
type
label
G Garuti
@ast
G Garuti
@en
G Garuti
@es
G Garuti
@nl
prefLabel
G Garuti
@ast
G Garuti
@en
G Garuti
@es
G Garuti
@nl
P106
P1153
35499397900
P31
P496
0000-0002-3904-820X